Protagenic Therapeutics, Inc. operates as a biotechnology company. It engages in the discovery and development of therapeutics to treat stress-related disorders including post-traumatic stress disorder, depression, anxiety, and drug & alcohol addiction. The firm offers PT00114 peptide-based formulations. The company was founded by Garo H. Armen, David A. Lovejoy, and Hartoun Hartounian on February 3, 1994 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
3
Frequently Asked Questions
What is Market Cap of Protagenic Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Protagenic Therapeutics Inc market cap is $2.69M.
What is the 52-week high for Protagenic Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Protagenic Therapeutics Inc 52 week high is $15.54 as of September 05, 2025.
What is the 52-week low for Protagenic Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Protagenic Therapeutics Inc 52 week low is $2.25 as of September 05, 2025.
What is Protagenic Therapeutics Inc stock price today?
Protagenic Therapeutics Inc stock price today is $3.15.
What was Protagenic Therapeutics Inc stock price yesterday?
Protagenic Therapeutics Inc stock price yesterday was $3.10.
What is the PE ratio of Protagenic Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Protagenic Therapeutics Inc’s P/E ratio is -0.24.
What is the Price-to-Book ratio of Protagenic Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Protagenic Therapeutics Inc P/B ratio is -18.8656.
What is the 50-day moving average of Protagenic Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Protagenic Therapeutics Inc 50-day moving average is $3.33.
How many employess does Protagenic Therapeutics Inc has?